Daphne Quimi Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

AMLX Quotes by TradingView

Daphne Quimi is of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 5,000 shares of AMLX, which is worth approximately $24,800. The most recent transaction as insider was on May 15, 2024, when has been sold 2,250 shares (Common Stock) at a price of $1.89 per share, resulting in proceeds of $4,252. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
n/a 12M change
Total Value Held $24,800

Daphne Quimi Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
BUY
Open market or private purchase
$4,252 $1.89 p/Share
2,250 Added 31.03%
5,000 Common Stock
May 14 2024
BUY
Open market or private purchase
$5,170 $1.88 p/Share
2,750 Added 50.0%
2,750 Common Stock

Also insider at

FOLD
AMICUS THERAPEUTICS, INC. Healthcare
Chief Financial Officer
IPSC
Century Therapeutics, Inc. Healthcare
Director
DQ

Daphne Quimi

Philadelphia, PA

Track Institutional and Insider Activities on AMLX

Follow Amylyx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMLX